![Maria Alba](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Maria Alba worked as Global Medical Leader at Amicus Therapeutics, Inc. Dr. Alba worked as Vice President-Clinical Research at Immunovant, Inc. from 2022 to 2026.
Dr. Alba earned a doctorate from The Catholic University of America.
Eerdere bekende functies van Maria Alba
| Bedrijven | Functie | Einde |
|---|---|---|
| IMMUNOVANT, INC. | Hoofd Techniek/Wetenschap/O&O | 31-03-2026 |
| AMICUS THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Opleiding van Maria Alba
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
30
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
Amicus Therapeutics, Inc.
 Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases | Health Technology |
The Catholic University of America
 The Catholic University of America Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunovant, Inc.
 Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
